Nonclinical safety evaluation of oral recombinant anti-human papilloma virus vaccine (RHPV 16 & 18): Regulatory toxicology studies in mice, rats and rabbits – An innovative approach-Reference-Cited by-同舟云学术

Nonclinical safety evaluation of oral recombinant anti-human papilloma virus vaccine (RHPV 16 & 18): Regulatory toxicology studies in mice, rats and rabbits – An innovative approach

Published:2021-01 Issue:5 Volume:39 Page:853-863
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Srinivasa Reddy Y.,Narendra Babu K.,Uday Kumar P.,Harishankar N.,Qadri S.S.Y.H.,Surekha M.V.,Hemalatha R.,Dinesh Kumar B.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference24 articles.

1. Prevalence of Human Papillomavirus subtypes 16 and 18 among Yemeni Patients with Cervical Cancer;Ahmed;Asian Pac J Cancer Prev,2017

2. Genes Regulated by HPV 16 E6 and High Expression of NFX1-123 in Cervical Cancers;Chintala;OncoTargets Therapy,2020

3. Human papillomavirus vaccines: current issues & future;Kawana;Indian J Med Res,2009

4. Bruni L, Albero G, Serrano B, Mena M, Gómez D, Muñoz J, Bosch FX, de Sanjosé S. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in India. Summary Report 17 June 2019

5. Quadrivalent Vaccine against Human Papilloma virus to Prevent High-Grade Cervical Lesions;Koutsky;N Engl J Med,2007

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intestinal Helminth Infection Impairs Oral and Parenteral Vaccine Efficacy;The Journal of Immunology;2023-06-05

2. Intestinal helminth infection impairs oral and parenteral vaccine efficacy;2022-09-23

3. Toxicological data of rats and rabbits: Sub-chronic testing of recombinant HPV vaccine through oral and intranasal routes;Data in Brief;2021-06